|4Apr 5, 4:01 PM ET

iBio, Inc. 4

4 · iBio, Inc. · Filed Apr 5, 2017

Insider Transaction Report

Form 4
Period: 2014-09-05
Chang Glenn
Director
Transactions
  • Award

    Stock Option (right to buy)

    2014-09-05$0.49/sh+60,000$29,400390,000 total
    Exercise: $0.49Exp: 2024-09-05Common Stock (60,000 underlying)
  • Award

    Stock Option (right to buy)

    2015-09-04$1.72/sh+100,000$172,000490,000 total
    Exercise: $1.72Exp: 2025-09-04Common Stock (100,000 underlying)
Footnotes (2)
  • [F1](1) Vesting starts 7/1/2014, in equal annual installments over three years.
  • [F2](2) Vesting starts 7/1/2015, in equal annual installments over year.

Documents

1 file
  • 4
    doc4_4650.xmlPrimary

    PRIMARY DOCUMENT